Mehta International Eye Institute is a center for patient care, vision research, and physician education, providing medical-surgical care for complex ophthalmic problems.

Mehta International Eye Institute

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Bernard Chauvin

Bausch + Lomb Corporation

Johnson & Johnson Vision is a company that focuses on eye health, providing products and services related to vision care from childhood myopia to presbyopia and cataracts.

Johnson & Johnson Vision

Practo is India's leading integrated healthcare company, focused on making quality healthcare accessible and affordable to all by connecting the entire healthcare ecosystem including patients, doctors, clinics, hospitals, pharmacies, and diagnostics in a seamless and cohesive manner. It offers a range of services from finding and booking appointments with verified doctors to consulting doctors online, getting medicines delivered, and conducting lab tests at home.

Metric
Company Name	Mehta International Eye Institute	Bausch + Lomb Corporation	Johnson & Johnson Vision	Practo
Symbol		BLCO
MSH ID	COM:MEHTAEYEINSTITUTE	COM:BAUSCH	COM:JJVISION	COM:PRACTO
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare	Medical - Instruments & Supplies	Medical Devices and Vision Care	Healthcare & Health Services
Country	IN	CA	US
Stage
Employee Count		13.30K		5.00K
Website	mehtaeyeinstitute.com	bausch.com	jjvision.com	practo.com
LinkedIn
Founders

Metric
Market Cap		5.43B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		4.15B
Revenue (LTM)
Revenue (NTM)
Gross Profit		2.50B
EBITDA		601M
Operating Income		130M
Net Income		-260M
EPS		-0.74
Diluted EPS		-0.74
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.96
Operating Profit Margin		0.12
EBITDA Margin		0.14
Net Profit Margin		-0.00
Return on Equity		0.02
Return on Assets		-0.00
Return on Capital Employed		0.05

COM:MEHTAEYEINSTITUTE

Mehta International Eye Institute

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-23.54
P/B Ratio		0.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		1.64
EV Multiple		17.67

Metric
Days Sales Outstanding		72.01
Days Payables Outstanding		82.99
Days Inventory Outstanding		1.62K
Operating Cycle		1.70K
Cash Conversion Cycle		1.07K
Asset Turnover		0.34

Metric
Operating Cash Flow		-17M
Free Cash Flow		-198M
Cash Flow to Debt		0.05
Operating Cash Flow/Sales		0.13
Free Cash Flow Yield		-0.00

Metric
Cash & Equivalents		331M
Accounts Receivable		-121M
Inventory		1.03B
Goodwill		4.58B
Debt to Capitalization		1.05
Debt to Assets		0.34
Current Ratio		1.78
Quick Ratio		1.03

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.02
R&D to Revenue		0.08
SG&A to Revenue